UNIGE document Scientific Article
previous document  unige:1036  next document
add to browser collection
Title

A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice

Authors
Proudfoot, Amanda
Published in Arteriosclerosis, Thrombosis, and Vascular Biology. 2008, vol. 28, no. 6, p. 1090-6
Abstract BACKGROUND: Atherosclerosis is a chronic inflammatory disease that represents the primary cause of death through coronary disease and stroke. Chemokines are known to play a crucial role in this disease by recruiting inflammatory leukocytes to the endothelium. Recently, the chemokine variant [44AANA47]-RANTES was shown to impair inflammatory cell recruitment in vivo by interfering with heparin binding and oligomerization. METHODS AND RESULTS: In this study we report that curative treatment with [44AANA47]-RANTES limits atherosclerotic plaque formation in LDLr-/- mice. This was associated with reduced infiltration of T cells and macrophages and reduced production of matrix metalloproteinase (MMP)-9. By contrast, the relative smooth muscle cell and collagen content was increased, indicating a more stable plaque phenotype. In addition, we provide evidence for direct inhibition of leukocyte recruitment into aortic root lesions, attenuated leukocyte rolling and arrest in mesenteric vessels, as well as a reduced proinflammatory response following Con A stimulation in vitro. CONCLUSIONS: Interference with chemokine oligomerization and chemokine/heparin interactions is a powerful novel approach that inhibits progression of established atherosclerosis in mice. By inhibiting leukocyte recruitment into plaques, [44AANA47]-RANTES mediates a less inflammatory plaque phenotype and thus reduced systemic inflammatory state.
Keywords AnimalsAorta/drug effects/metabolism/pathologyAtherosclerosis/metabolism/pathology/prevention & controlChemokine CCL2/metabolismChemokine CCL5/antagonists & inhibitorsChemokines/pharmacologyCollagen/metabolismDisease Models, AnimalDisease ProgressionHeparin/metabolismLeukocytes/drug effects/physiologyMaleMatrix Metalloproteinase 9/metabolismMiceMice, Inbred C57BLMice, TransgenicReceptors, CCR2/metabolismReceptors, CCR5/metabolismReceptors, LDL/genetics/metabolism
Identifiers
PMID: 18388327
Full text
Structures
Research groups Biologie du myocarde (22)
L'athérosclérose et ses complications cliniques (591)
Le rôle du système endocannabinoïde dans l'athérosclérose (882)
Citation
(ISO format)
BRAUNERSREUTHER, Vincent et al. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. In: Arteriosclerosis, Thrombosis, and Vascular Biology, 2008, vol. 28, n° 6, p. 1090-6. https://archive-ouverte.unige.ch/unige:1036

188 hits

2 downloads

Update

Deposited on : 2009-02-27

Export document
Format :
Citation style :